Immediate Impact

1 by Nobel laureates 2 from Science/Nature 52 standout
Sub-graph 1 of 24

Citing Papers

EASL Clinical Practice Guidelines on the management of hepatitis B virus infection
2025 Standout
The emergence of artemisinin partial resistance in Africa: how do we respond?
2024 Standout
3 intermediate papers

Works of Zékiba Tarnagda being referenced

Artesunate-Amodiaquine and Artemether-Lumefantrine Therapies and Selection of Pfcrt and Pfmdr1 Alleles in Nanoro, Burkina Faso
2016
Effectiveness and safety of artemether–lumefantrine versus artesunate–amodiaquine for unsupervised treatment of uncomplicated falciparum malaria in patients of all age groups in Nanoro, Burkina Faso: a randomized open label trial
2015
and 2 more

Author Peers

Author Last Decade Papers Cites
Zékiba Tarnagda 603 277 197 214 67 1.2k
Y. Weisman 600 401 174 181 71 1.3k
S R Palmer 296 464 66 62 40 1.3k
Regina Allwinn 816 553 276 76 56 1.4k
Márcio Neves Bóia 426 439 386 37 75 1.4k
Kawsar R. Talaat 583 717 361 52 50 1.3k
Leslie A. Reperant 606 494 180 111 31 1.2k
M Jegathesan 114 450 123 99 58 1.4k
L. A. Glasgow 759 324 74 43 52 1.4k
P Ravisse 335 305 85 32 67 966
Fausto Edmundo Lima Pereira 519 277 99 99 86 1.3k

All Works

Loading papers...

Rankless by CCL
2026